首页> 外文期刊>Pharmacology and Therapeutics: The Journal of the International Encyclopedia of Pharmacology and Therapeutics >Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase.
【24h】

Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase.

机译:病毒直接抑制PKR(干扰素诱导的蛋白激酶)介导的干扰素抗性的分子机制。

获取原文
获取原文并翻译 | 示例
           

摘要

The interferon (IFN)-induced cellular antiviral response is the first line of defense against viral infection within an animal host. In order to establish a productive infection, eukaryotic viruses must first overcome the IFN-induced blocks imposed on viral replication. The double-stranded RNA-activated protein kinase (PKR) is a key component mediating the antiviral actions of IFN. This IFN-induced protein kinase can restrict viral replication through its ability to phosphorylate the protein synthesis initiation factor eukaryotic initiation factor-2 alpha-subunit and reduce levels of viral protein synthesis. Viruses, therefore, must block the function of PKR in order to avoid these deleterious antiviral effects associated with PKR activity. Indeed, many viruses have developed effective measures to repress PKR activity during infection. This review will focus primarily on an overview of the different molecular mechanisms employed by these viruses to meet a common goal: the inhibition of PKR function, uncompromised viral protein synthesis, and unrestricted virus replication. The past few years have seen exciting new advances in this area. Rather unexpectedly, this area of research has benefited from the use of the yeast system to study PKR. Other recent advances include studies on PKR regulation by the herpes simplex viruses and data from our laboratory on the medically important hepatitis C viruses. We speculate that IFN is ineffective as a therapeutic agent against hepatitis C virus because the virus can effectively repress PKR function. Finally, we will discuss briefly the future directions of this PKR field.
机译:干扰素(IFN)诱导的细胞抗病毒反应是抵御动物宿主内病毒感染的第一道防线。为了建立有效的感染,真核病毒必须首先克服IFN诱导的病毒复制障碍。双链RNA活化蛋白激酶(PKR)是介导IFN抗病毒作用的关键成分。这种IFN诱导的蛋白激酶可以通过磷酸化蛋白合成起始因子真核起始因子2α亚基并降低病毒蛋白合成水平来限制病毒复制。因此,病毒必须阻断PKR的功能,以避免这些与PKR活性相关的有害抗病毒作用。实际上,许多病毒已经开发出有效的措施来抑制感染期间的PKR活性。这篇综述主要集中在这些病毒为达到共同目标所采用的不同分子机制的概述:抑制PKR功能,不妥协的病毒蛋白合成和不受限的病毒复制。过去几年中,该领域取得了令人兴奋的新进展。出乎意料的是,该领域的研究得益于酵母系统对PKR的研究。其他最近的进展包括单纯疱疹病毒对PKR调节的研究以及我们实验室中有关医学上重要的丙型肝炎病毒的数据。我们推测IFN不能有效治疗丙型肝炎病毒,因为该病毒可以有效抑制PKR功能。最后,我们将简要讨论该PKR领域的未来方向。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号